Patient recruitment strategy for family studies investigating novel genetic causes of maturity-onset diabetes of the young

Authors

  • BA Barrow
  • S Ellard
  • MH Shepherd
  • MI McCarthy
  • AT Hattersley
  • AL Gloyn

DOI:

https://doi.org/10.1002/edn.14

Keywords:

genetics of diabetes, maturity-onset diabetes of the young, glucokinase, patient recruitment

Abstract

Abstract

A small but significant minority of patients with diabetes have a defect in a single gene that is responsible for their diabetes. Determining the genetic subtype of their diabetes not only offers insights into the pathophysiology of diabetes, but also helps clinicians to determine the most appropriate treatment.

Maturity-onset diabetes of the young (MODY) is an autosomal dominant subtype of diabetes. Mutations in the glucokinase (GCK) gene result in mildly elevated fasting hyperglycaemia (>5.5mmol/L) throughout life. Our aim was to recruit families with this phenotype who do not have a GCK gene mutation in order to identify a novel genetic cause for their diabetes.

The UK MODY database, which details all subjects who have undergone a genetic test for MODY, was used as a resource to identify patients with a phenotype suggestive of GCK-MODY in whom no GCK mutation had been found. Interested families were visited in their homes and blood was taken for biochemical analysis and DNA extraction. Anthropometric measurements were recorded on all recruited family members.

Twelve probands were identified but two were excluded as their phenotype was no longer consistent with GCK-MODY. Four were already consented for research and the remaining six were contacted through the MODY link nurses. To date, six multi-generation families have been collected.

Our novel recruitment strategy, involving the UK MODY database in combination with a research nurse and a nationwide team of MODY link nurses, has proved successful in identifying a small subset of families who are a resource for genetic studies. Our unique approach provides a recruitment protocol that can be adapted for other genetic studies.

Downloads

Download data is not yet available.

References

Frayling TM, Evans JC, Bulman MP, et aL Beta-cell genes and diabetes: molecular and clinical characteriza-tion of mutations in transcription factors. Diabetes 2001; 50(Suppl 1): S94—S100.

Shepherd M, Sparkes AC, Hattersley AT. Genetic testing in maturity onset diabetes of the young (MODY); a new challenge for the diabetic clinic. Pract Diabetes Int 2001; 18: 16–21.

Pearson ER, Starkey BJ, Powell RJ, et aL Genetic aetiology of hypergly-caemia determines response to treat-ment in diabetes. Lancet 2003; 362(9392): 1275–1281.

Owen K, Hattersley AT. Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization. Best Pract Res Clin Endocrinol Metab 2001; 15(3): 309–323.

Lambert AP, Ellard S, Allen LI, et aL Identifying hepatic nuclear factor 1 alpha mutations in children and young adults with a clinical diagnosis of type 1 diabetes. Diabetes Care 2003; 26(2): 333–337.

Shepherd MH, Hattersley AT, Ellard S. Integrating genetics into diabetes care: a new role for DSNs. J Nursing 2003; 7(8): 289–292.

Gloyn AL. Glucokinase (GCK) muta-tions in hyper- and hypoglycemia: Maturity-onset diabetes of the young, permanent neonatal dia-betes, and hyperinsulinemia of infancy. Hum Mutat 2003; 22(5): 353–362.

Downloads

Published

2005-04-01

How to Cite

Barrow, B., Ellard, S., Shepherd, M., McCarthy, M., Hattersley, A., & Gloyn, A. (2005). Patient recruitment strategy for family studies investigating novel genetic causes of maturity-onset diabetes of the young. International Diabetes Nursing, 2(1), 24–29. https://doi.org/10.1002/edn.14

Issue

Section

Research Article